Live Breaking News & Updates on Vaccine industrial complex
Stay updated with breaking news from Vaccine industrial complex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers have identified fragments from influenza B viruses that the immune system consistently recognise, offering promising targets for a universal influenza B vaccine.
Ixchiq is a single shot live attenuated vaccine for the prevention of chikungunya virus vaccine which provided immunity to over 98% of participants in a phase 3 clinical trial. The vaccine was well tolerated and had an overall adverse event profile similar to other vaccines currently on the market. The Latest A 2023 phase 3
AstraZeneca, following global outrage over the side effects of the vaccine, said on Tuesday that the benefits of the vaccine “far outweigh” the risks of “extremely rare” potential side effects. - Benefits Of Covishield COVID Vaccine Far Outweigh Extremely Rare Potential Side Effects: AstraZeneca
The registration of a new vaccine which took around 50 years to develop, is set to offer older New Zealanders protection against RSV-associated lower...
The University of Oxford has announced plans to establish a new Poonawalla Vaccines Research building with a funding commitment of GBP 50 million from India’s Serum Life Sciences. Serum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed research facility will focus on vaccinology,
AstraZeneca, in collaboration with the University of Oxford, admits its Covid-19 vaccine can cause a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS). The admission comes amidst a lawsuit alleging severe harm and deaths caused by the vaccine. Kate, wife of a victim, demands an apology and fair compensation after a three-year struggle. The lawsuit, involving fifty-one cases, seeks around £100 million in compensation.
International Business News: AstraZeneca, in collaboration with the University of Oxford, has acknowledged that its COVID-19 vaccine carries the risk of causing a rare side effect
UK News: AstraZeneca has stated in legal papers that its Covid vaccine has the potential to result in an uncommon side effect, according to a report by the UK’